RE:RE:RE:RE:RE:RE:RE:RE:Shareprice vs. Valuequinlash - (5/12/2021 4:51:08 PM)
RE:RE:RE:RE:RE:RE:RE:Shareprice vs. Value
Anyone buying in that range with an investment timeline of 30 days or less, yes, I would say that was FOMO. Anyone who added at $14 or under are still under the fundamentals on the SP vs. compariable stocks. Timelines on fundamentals should be viewed as requiring a longer timelines that need to be measured in years (and the number of heartburns you have while waiting).
Having a strategy of making partial buys then leaving cash aside to average down on a dip certainly helps alot. The market selloff we seen in 2020 (across everything under the sun) certainly was trying for many but those who were long, and could do it, should of taken the opportunity to average down the best they could under the circumstances.
To the point of an earlier poster, the SP has yet to recover to the pre C-19 pricing of late 2019 / early 2020. That can be viewed as a positive or as a negative depending on how confident you are in the Cannabis sector being a success and how well you see HEXO doing within the sector Nice speech Queen - what article did you copy this one from?
In regards to timelines - no question COVID had a negative impact on most sectors in 2020, but you conveniently forget that Hexo's shared price was $44.00 at the end of April 2019 - and declined to $8.28 at the end of December 2019
Hexo's sp continued to decline and hovered at just under $4.00 for the majority of COVID 2020
That $6.00 per share in2019 had nothing to do with Covid - it had to do with the fundamentals you mention, as well as the fact that Hexo had to do 5 financings/public offerings in 2020 - not just because of COVID - but because of the lack of competent management - general and financial controls.
Is it logical management to you to buy a $265 million company during a pandemic? is logical to sell it off 6 months later - and write of the entire amount?
In regards to Hexo's recovery - thats tarted in November along with most cannabis stocks with the U.S. election and the coomon view that Democrats would legalize cannabis.
Nothing has changed with Hexo and it's operations - they announced Zena purchase in january - another $255 million when hey hadn't recovered from 2020 and Newstrike yet.
Share price is falling now - in part due to the market sure - but in Hexo's case mostly because it's same old, same old - and Mr Market has caught up to the realities of Hexo.
More bad news to follow shortly.